The Scientist

» research funding and immunology

Most Recent

image: Polio Vaccine Pioneer Dies

Polio Vaccine Pioneer Dies

By | May 2, 2017

Julius Youngner collaborated with Jonas Salk on the polio vaccine, and later identified interferon gamma and contributed to an equine influenza vaccine.

0 Comments

Time-lapse imaging shows the immune cells transferring chemical signals during pigment pattern formation in developing zebrafish.

0 Comments

image: Infographic: How the Zebrafish Got Its Stripes

Infographic: How the Zebrafish Got Its Stripes

By | May 1, 2017

Immune cells called macrophages shuttle cellular messages in the skin.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | May 1, 2017

Climate change, research funding, race, and much more

0 Comments

image: Marching Into an Uncertain Future

Marching Into an Uncertain Future

By | April 20, 2017

Can professional organizations and societies parlay the groundswell of support culminating in this weekend’s March for Science into more-effective science advocacy?

1 Comment

image: Report: Boost Funds for Basic Science in Canada

Report: Boost Funds for Basic Science in Canada

By | April 12, 2017

An independent review of Canadian science reveals a need for additional funds to investigator-led, basic research.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS